ATC Group: R01BA52 Pseudoephedrine, combinations

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R01BA52 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R01 Nasal preparations
3 R01B Nasal decongestants for systemic use
4 R01BA Sympathomimetics
5 R01BA52 Pseudoephedrine, combinations

Related product monographs

Document Type Information Source  
 ACTIFED Syrup MPI, EU: SmPC Health Products Regulatory Authority (IE)
 MEDOFED Oral solution MPI, EU: SmPC Υπουργείο Υγείας (CY)
 ZYRTEC-D Prolonged release tablet MPI, EU: SmPC Marketing Authorisation Holder

Medicines classified under this ATC code globally

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Lithuania (LT)

Malta (MT)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.